Syneos Health ® today announced new and expanded strategic partnerships that strengthen its cutting-edge, AI ecosystem. These innovative solutions represent best-in-breed technologies that help ...

MORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today ...

MORRISVILLE, N.C., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today reported financial results for the three and ...

Syneos Health inked a multiyear deal with Microsoft to further develop a platform that leverages machine learning to support and speed the analysis, design and operations of clinical trials and ...

MORRISVILLE – Syneos Health is making a lot of news today with its financial report topping Wall Street expectations and Wednesday evening’s announcement that it is acquiring Synteract, which also has ...

Syneos Health had been eyeing a sale since March 2020. Apparently, for several years, many of the smaller drugmakers upon which Syneos relied for a big slice of its CRO business had delayed or dropped ...

Syneos Health cemented a multi-year deal to use Microsoft’s platform for deploying artificial intelligence (AI) in its clinical trials and commercial programs. The agreement announced this week ...

(Reuters) -Syneos Health Inc is making a new effort to sell itself after a reduced backlog of contracts for providing clinical research to drug developers led to a 52% plunge in its shares over the ...

Narrow-moat Syneos SYNH announced it will be acquired by a consortium of three private investment firms (Elliott Investment Management, Patient Square Capital, and Veritas Capital) for $43 per share ...

March 9 (Reuters) - Syneos Health Inc SYNH.O, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Syneos ...

Syneos Health, a leading biopharmaceutical contract research organization, agreed to be acquired for $7.1 billion by a group of private equity firms. Elliott Investment Management, Patient Square ...